Skip to main content
ARDX
NASDAQ Life Sciences

Ardelyx Posts $127.7M in Q3 Revenue, Topping Last Quarter's Record

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$3.05
Mkt Cap
$755.038M
52W Low
$2.955
52W High
$8.4
52W Position info
3.2% above low
Off High info
64% below high
Rel. Volume info
1.2× avg
Market data snapshot near publication time

ARDX is trading near its 52-week low of $2.955 (3.2% above the low).

Summary

Ardelyx reported third-quarter revenue of $127.7M, ahead of the $120.9M it booked in Q2 and the $118.1M in Q2 product revenue, with Q3 product sales of USD 125.455 Million. That extends the top-line growth trend that drove Q2's 24% year-over-year increase, though the prior quarter came with a $60M cut to full-year IBSRELA guidance that has kept the stock pinned near its 52-week low of $2.955. The quarter's bottom line came in at a loss of $737,000, or 0c per share. The revenue print alone doesn't resolve the guidance question — the market will want the updated IBSRELA outlook and any commentary on the commercial organization after Chief Commercial Officer Eric Foster's August departure. Cash stood at $281.8M at the end of Q2, so the revenue trajectory matters more for the growth story than for liquidity.

At the time of this announcement, ARDX was trading at $3.05 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $755M. The 52-week trading range was $2.96 to $8.40. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

ARDX - Latest Insights

ARDX
Nov 03, 2026, 4:05 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $3.08
Real-time Price: $3.21 info
Change: +$0.130 (+4%) info
Market Cap: $808.163M info
ARDX
Nov 03, 2026, 4:03 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $3.04
Real-time Price: $3.21 info
Change: +$0.1692 (+6%) info
Market Cap: $808.163M info
ARDX
Aug 17, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $4.04
Real-time Price: $3.21 info
Change: -$0.830 (-21%) info
Market Cap: $808.163M info
ARDX
Aug 06, 2026, 4:49 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $4.08
Real-time Price: $3.21 info
Change: -$0.870 (-21%) info
Market Cap: $808.163M info
ARDX
Aug 06, 2026, 4:12 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $4.50
Real-time Price: $3.21 info
Change: -$1.29 (-29%) info
Market Cap: $808.163M info